Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
37
CRM Quote, Financials, Valuation and Earnings
Last price:
$278.60
Seasonality move
:
5.19%
Day range:
$276.08 - $282.73
52-week range:
$212.00 - $369.00
Dividend yield:
0.57%
P/E ratio:
44.14x
P/S ratio:
7.21x
P/B ratio:
4.41x
Volume:
4.5M
Avg. volume:
7.6M
1-year change:
-4.61%
Market cap:
$269.8B
Revenue:
$37.9B
EPS (TTM):
$6.36
Salesforce Number of Institutional Trades
Salesforce Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$148.1B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$245.6B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Salesforce Institutional Ownership
-
What Percentage Of CRM Is Owned by Institutions?
-- of CRM is owned by institutions.
-
How Many Institutions Own CRM Shares?
Salesforce stock is owned by 4,759 institutional shareholders at this time.
-
Have Institutions Been Buying CRM Stock?
Yes, institutions have bought 277.6M shares of CRM in the last quarter.
-
Have Institutions Been Selling CRM Stock?
Yes, institutions have sold 439.7M shares of CRM over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
